| Staurosporine | IC50 | 1.8 [1] |
| 4-Amino-5-(4-Phenoxyphenyl)-7h-Pyrrolo[2,3-D]pyrimidin-7-Yl-Cyclopentane | IC50 | 2.0 [1] |
| Dasatinib | IC50 | 0.4 [1], 1.0 [2], 3.0 [3], 4.0 [4] |
| N-(2-Chloro-6-methylphenyl)-2-[(cyclopropylcarbonyl)amino]-1,3-thiazole-5-carboxamide | IC50 | 35.0 [1], 880.0 [2] |
| 5-(4-Phenoxyphenyl)-7-isopropyl-7H-pyrrolo[2,3-d]pyrimidine-4-amine | IC50 | 1.0 [1], 10.0 [2], 11.0 [3] |
| 5-(4-Phenoxyphenyl)-7-tert-butyl-7H-pyrrolo[2,3-d]pyrimidine-4-amine | IC50 | 2.0 [1], 13.8 [2], 14.0 [3], 75.0 [4] |
| Piceatannol | IC50 | 5000.0 [1], 66000.0 [2], 82000.0 [3] |
| Doramapimod | IC50 | 1000.0 [1], 2100.0 [2], 20000.0 [3], 35000.0 [4] |
| 1-(Tert-Butyl)-3-(p-tolyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine | IC50 | 5.0 [1], 151.0 [2], 250.0 [3] |
| 1-(Tert-Butyl)-3-(p-tolyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine | Ki | 63.1 [1] |
| 7-[cis-4-(4-Methylpiperazin-1-Yl)cyclohexyl]-5-(4-Phenoxyphenyl)-7h-Pyrrolo[2,3-D]pyrimidin-4-Amine | IC50 | 15.0 [1], 240.0 [2] |
| N-(2-Bromophenyl)imidazo[1,5-a]quinoxalin-4-amine | IC50 | 170.0 [1] |
| Unii-mbe6kwv0QI | IC50 | 4.0 [1] |
| Unii-mbe6kwv0QI | Ki | 4.0 [1], 5.5 [2] |
| 3-(2-Aminoquinazolin-6-Yl)-4-Methyl-N-[3-(Trifluoromethyl)phenyl]benzamide | IC50 | 0.2 [1], 1.0 [2] |
| 5-(3-Phenoxyphenyl)-7-cyclopentyl-7H-pyrrolo[2,3-d]pyrimidine-4-amine | IC50 | 140.0 [1], 1180.0 [2], 1200.0 [3], 10000.0 [4] |
| 2-[4-Amino-5-(4-phenoxy-phenyl)-pyrrolo[2,3-d]pyrimidin-7-yl]-cyclopentanol | IC50 | 1.0 [1], 8.0 [2], 240.0 [3], 1320.0 [4] |
| 3-[4-Amino-5-(4-phenoxy-phenyl)-pyrrolo[2,3-d]pyrimidin-7-yl]-cyclopentanol | IC50 | 1.0 [1], 5.0 [2], 544.0 [3] |
| 4-[4-Amino-5-(4-phenoxyphenyl)pyrrolo[2,3-d]pyrimidin-7-yl]cyclopentane-1,2-diol | IC50 | 2.0 [1], 5.0 [2], 23.0 [3], 317.0 [4] |
| 2-PropenaMide, N-[cis-4-[4-aMino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyriMidin-1-yl]cyclohexyl]- | IC50 | 0.88 [1], 1.0 [2] |
| Imatinib | IC50 | 160.0 [1], 320.0 [2] |
| Crizotinib | IC50 | 1.0 [1], 2741.0 [2] |
| 1-Tert-butyl-3-(4-chlorophenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine | IC50 | 4.0 [1] |
| 1-Tert-butyl-3-(4-chlorophenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine | Ki | 0.79 [1] |
| Saracatinib | IC50 | 4.0 [1] |
| Damnacanthal | IC50 | 17.0 [1], 620.0 [2] |
| Tyrphostin A46 | IC50 | 7000.0 [1], 22000.0 [2] |
| N-(2-Chloro-6-methylphenyl)-7,8-dimethoxyimidazo[1,5-a]quinoxalin-4-amine | IC50 | 2.0 [1] |
| N-(2-Chloro-6-methylphenyl)-7-methoxyimidazo[1,5-a]quinoxalin-4-amine | IC50 | 8.7 [1] |
| N-(2-Chloro-6-methylphenyl)-8-methoxyimidazo[1,5-a]quinoxalin-4-amine | IC50 | 3.0 [1], 280.0 [2] |
| N-(2-Chloro-6-methylphenyl)imidazo[1,5-a]quinoxalin-4-amine | IC50 | 9.0 [1] |
| N4-(2-Chloro-6-methylphenyl)imidazo[1,5-a]quinoxaline-4,7-diamine | IC50 | 21.0 [1] |
| N-(2,6-Dimethylphenyl)-6,7-dimethoxyimidazo[1,5-a]quinoxalin-4-amine | IC50 | 2.4 [1] |
| 7,8-Dihydroxyisoquinoline-3-carboxamide | IC50 | 500.0 [1] |
| 5-Thiazolecarboxamide, 2-amino-4-methyl-N-(2,4,6-trimethylphenyl)- | IC50 | 3200.0 [1], 5000.0 [2] |
| N-(2-Chloro-6-methylphenyl)-2-[(phenylcarbonyl)amino]-1,3-thiazole-5-carboxamide | IC50 | 890.0 [1] |
| N-(2,6-Dimethylphenyl)-7,8-dimethoxyimidazo[1,5-a]quinoxalin-4-amine | IC50 | 2.4 [1] |
| N-(2-Bromophenyl)-1-methylimidazo[1,5-a]quinoxalin-4-amine | IC50 | 180.0 [1] |
| N-(2-Chloro-6-methylphenyl)-7-morpholinoimidazo[1,5-a]quinoxalin-4-amine | IC50 | 6.0 [1] |
| N-(2,6-Diethylphenyl)imidazo[1,5-a]quinoxalin-4-amine | IC50 | 1690.0 [1] |
| N-Phenylimidazo[1,5-a]quinoxalin-4-amine | IC50 | 890.0 [1] |
| N-(2,6-Dimethylphenyl)imidazo[1,5-a]quinoxalin-4-amine | IC50 | 16.0 [1] |
| N-(2-Fluorophenyl)imidazo[1,5-a]quinoxalin-4-amine | IC50 | 390.0 [1] |
| N-(2-Chloro-4-methylphenyl)imidazo[1,5-a]quinoxalin-4-amine | IC50 | 240.0 [1] |
| N-(2-Chloro-6-methylphenyl)-6-methoxyimidazo[1,5-a]quinoxalin-4-amine | IC50 | 3.0 [1], 280.0 [2] |
| 7-Bromo-N-(2-chloro-6-methylphenyl)imidazo[1,5-a]quinoxalin-4-amine | IC50 | 14.0 [1] |
| N-(2-Methoxyphenyl)imidazo[1,5-a]quinoxalin-4-amine | IC50 | 5520.0 [1] |
| 4-(2-Chloro-6-methylanilino)imidazo[1,5-a]quinoxaline-7-carboxamide | IC50 | 30.0 [1] |
| N-(2-Chlorophenyl)imidazo[1,5-a]quinoxalin-4-amine | IC50 | 60.0 [1] |
| N-(4-(2-Chloro-6-methylphenylamino)imidazo[1,5-a]quinoxalin-7-yl)acetamide | IC50 | 11.0 [1] |
| N-(2-Chlorophenyl)-3-methylimidazo[1,5-a]quinoxalin-4-amine | IC50 | 30.0 [1] |
| N-(2,6-Difluorophenyl)imidazo[1,5-a]quinoxalin-4-amine | IC50 | 360.0 [1] |
| N-(2,6-Dichlorophenyl)imidazo[1,5-a]quinoxalin-4-amine | IC50 | 9.0 [1] |
| N-(2,6-Dimethylphenyl)-9-nitroimidazo[1,5-a]quinoxalin-4-amine | IC50 | 100.0 [1] |
| N-(3-Fluorophenyl)imidazo[1,5-a]quinoxalin-4-amine | IC50 | 1330.0 [1] |
| N-Mesitylimidazo[1,5-a]quinoxalin-4-amine | IC50 | 40.0 [1] |
| N-(2,6-Dibromophenyl)imidazo[1,5-a]quinoxalin-4-amine | IC50 | 50.0 [1] |
| N-(2-Chloro-4,6-dimethylphenyl)imidazo[1,5-a]quinoxalin-4-amine | IC50 | 30.0 [1] |
| N4-(2-Chloro-6-methylphenyl)-N7,N7-diethylimidazo[1,5-a]quinoxaline-4,7-diamine | IC50 | 9.0 [1] |
| 2-[[(Tert-butyloxy)carbonyl]-amino]-4-methyl-N-(2,4,6-trimethylphenyl)-1,3-thiazole-5-carboxamide | IC50 | 1500.0 [1], 3000.0 [2] |
| N-(2-Chloro-6-methylphenyl)-6,7-dimethoxyimidazo[1,5-a]quinoxalin-4-amine | IC50 | 2.0 [1] |
| 7-Hydroxy-6-oxo-2,6-dihydroisoquinoline-3-carboxamide | IC50 | 1900000.0 [1] |
| Quercetin | IC50 | 13000.0 [1] |
| Ibrutinib | IC50 | 2.0 [1] |
| Rosmarinic acid | IC50 | 24000.0 [1], 55000.0 [2] |
| Tofacitinib | IC50 | 3870.0 [1] |
| Nintedanib | IC50 | 16.0 [1] |
| Ceritinib | IC50 | 560.0 [1], 672.0 [2] |
| Nvp-aew541 | IC50 | 5600.0 [1] |
| Bms-536924 | IC50 | 341.0 [1] |
| PDGF Receptor Tyrosine Kinase Inhibitor IV | IC50 | 100.0 [1] |
| Amg-458 | IC50 | 730.0 [1], 1000.0 [2] |
| JNJ-28312141 free base | IC50 | 88.0 [1], 3900.0 [2] |
| A-770041 | IC50 | 80.0 [1], 147.0 [2] |
| Lavendustin c | IC50 | 10000.0 [1] |
| (4S,6Z,9S,10S)-9,10,18-Trihydroxy-16-methoxy-4-methyl-3-oxabicyclo[12.4.0]octadeca-1(14),6,15,17-tetraene-2,8-dione | IC50 | 750.0 [1], 6200.0 [2] |
| 7-(2,6-Dichlorophenyl)-5-methyl-N-[4-(2-pyrrolidin-1-ylethoxy)phenyl]-1,2,4-benzotriazin-3-amine | Ki | 29.4 [1] |
| Aim-100 | IC50 | 122.0 [1] |
| Aminogenistein | IC50 | 1000.0 [1], 1200.0 [2] |
| N-(4-Chlorophenyl)-6-[(6,7-dimethoxyquinolin-4-yl)oxy]naphthalene-1-carboxamide | IC50 | 38.0 [1] |
| Bms-986142 | IC50 | 71.0 [1], 3800.0 [2] |
| N-Acetyl-O-phosphono-Tyr-Glu-Glu-Ile-Glu | IC50 | 1300.0 [1], 1500.0 [2] |
| N-[1-[(3-Fluorophenyl)methyl]indazol-5-yl]-5-[[(2S)-morpholin-2-yl]methoxymethyl]pyrrolo[2,1-f][1,2,4]triazin-4-amine | IC50 | 5000.0 [1] |
| 9H-Imidazo(4,5-H)isoquinolin-9-one, 2-((2,6-dichlorophenyl)amino)-1,8-dihydro-6,7-dimethyl- | IC50 | 26.0 [1], 110.0 [2] |
| 4-N-(2-Chloro-6-methylphenyl)-7-N-[2-(dimethylamino)ethyl]-8-methoxyimidazo[1,5-a]quinoxaline-4,7-diamine | IC50 | 1.7 [1] |
| Lck Inhibitor | IC50 | 7.0 [1], 1600.0 [2] |
| 4'-Amino-7-hydroxyflavone | IC50 | 100000.0 [1], 138000.0 [2] |
| N-(2-Chloro-6-methylphenyl)-8-fluoroimidazo[1,5-a]quinoxalin-4-amine | IC50 | 26.0 [1] |
| 2-Methyl-N-pyrimidin-5-yl-5-[[3-(trifluoromethyl)benzoyl]amino]benzamide | IC50 | 239.0 [1], 240.0 [2] |
| N4-(2-Chloro-6-methylphenyl)imidazo[1,5-a]quinoxaline-4,8-diamine | IC50 | 7.0 [1] |
| 6-[4-[2-(Dimethylamino)ethoxy]phenyl]-N-[[(2S)-oxolan-2-yl]methyl]-5-phenylfuro[2,3-d]pyrimidin-4-amine | IC50 | 6.0 [1] |
| Pyrazolo[3,4-d]pyrimidine 5 | IC50 | 93.0 [1] |
| cis-3-[4-Amino-7-(3-azetidin-1-ylmethyl-cyclobutyl)-7H-pyrrolo[2,3-d]pyrimidin-5-yl]-phenol | IC50 | 690.0 [1] |
| 7-[3-(Azetidin-1-ylmethyl)cyclobutyl]-5-[3-[[(2S)-oxolan-2-yl]methoxy]phenyl]pyrrolo[2,3-d]pyrimidin-4-amine | IC50 | 8900.0 [1] |
| 2-[[(Tert-butyloxy)carbonyl]-amino]-4-methyl-N-(2-chloro-6-methylphenyl)-1,3-thiazole-5-carboxamide | IC50 | 28000.0 [1] |
| 4-Methyl-3-(3-(pyrimidin-4-yl)pyridin-2-ylamino)-N-(3-(trifluoromethyl)phenyl)benzamide | IC50 | 3.5 [1], 25.0 [2] |
| (NE)-N-[[4-(2-chloro-6-methylanilino)-6,7-dimethoxyimidazo[1,5-a]quinoxalin-1-yl]methylidene]hydroxylamine | IC50 | 4.3 [1] |
| N-(2-Amino-5-pyrimidinyl)-2-methyl-5-(((3-(trifluoromethyl)phenyl)carbonyl)amino)benzamide | IC50 | 14.0 [1], 149.0 [2] |
| 4-Methyl-3-[2-(methylamino)quinazolin-6-yl]-N-[3-(trifluoromethyl)phenyl]benzamide | IC50 | 0.27 [1], 0.3 [2] |
| 4'-Aminoflavone | IC50 | 200000.0 [1], 210000.0 [2] |